Skip to content

POWERPACK – Cellsonic + Cardio MedBed


Short version of this study
The Cardio Med Bed improves peripheral arterial function and nitric oxide bioavailabity which will impact the abnormal glucose tolerance (AGT). This study was to evaluate the effects of Cardio Med Bed on arterial function, glucose tolerance and skeletal muscle. This study found that GLUT4 transporter, who’s main role is to provide the insulin-stimulated glucose uptake by
adipose tissue, skeletal muscle and the heart (for Type 2 Diabetes) was increased by 47%
following Cardio Med Bed use.
Read Study link:

Science Direct published Sept 2003- Cardio Med Bed for the relief of angina in patients with diabetes: safety, efficacy and 1-year clinical outcomes

Springer link published June 2016 – Cardio Med Bed decreases advanced glycation end products and proinflammatory cytokines in patients with non-insulin-dependent type II diabetes mellitus for up to 6 months following treatment

Wiley Online Library published Mar 2020
Expert consensus on the clinical application of external counterpulsation in elderly people (2019)

Frontiers in Physiology published Feb 2021
The Endothelium as a Therapeutic Target in Diabetes: A Narrative Review and Perspective

Short version of this study
The Cardio Med Bed improves peripheral arterial function and nitric oxide bioavailabity which will impact the abnormal glucose tolerance (AGT). This study was to evaluate the effects of Cardio Med Bed on arterial function, glucose tolerance and skeletal muscle. This study found that GLUT4 transporter, who’s main role is to provide the insulin-stimulated glucose uptake by
adipose tissue, skeletal muscle and the heart (for Type 2 Diabetes) was increased by 47% following Cardio Med Bed use.
Read Study link

Other supportive studies
Science Direct published Sept 2003- Cardio Med Bed for the relief of angina in patients with diabetes: safety, efficacy and 1-year clinical outcomes

Springer link published June 2016 – Cardio Med Bed decreases advanced glycation end products and proinflammatory cytokines in patients with non-insulin-dependent type II diabetes mellitus for up to 6 months following treatment

Wiley Online Library published Mar 2020
Expert consensus on the clinical application of enhanced external counterpulsation in elderly people (2019)

Frontiers in Physiology published Feb 2021
The Endothelium as a Therapeutic Target in Diabetes: A Narrative Review and Perspective

PubMed -Dec 2007
J Am Coll Cardiol. 2007 Dec 18;50(25):2441
The technique of counterpulsation, studied for almost one-half century now, is considered a safe, highly beneficial, low-cost, non-invasive treatment for these angina patients, and now for heart failure patients as well.

PubMed -Nov 2021
J Cardiovasc Thorac Res. 2021;13(4):265-276. doi: 10.34172/jcvtr.2021.50. Epub 2021 Nov 23
The results indicate the safety and effectiveness of the Cardio Med Bed in patients with angina pectoris and indicate the usefulness of this treatment in these patients.

PubMed – Aug 2022
Comput Methods Biomech Biomed Engin . 2022 Aug;25(10):1169-1179. doi:
10.1080/10255842.2021.2005034. Epub 2021 Nov 19.
Numerical analysis of hemodynamic effect under Cardio MedBed – different external counterpulsation frequency for cerebrovascular disease: a simulation study.

PubMed – Sep 2022
Rezapour A, Naghdi S, Ghiasvand H, Moradi T, Kabir MJ, Yousefzadeh N.
Med J Islam Repub Iran. 2022 Sep 1;36:100. doi: 10.47176/mjiri.36.100. eCollection 2022.
A Systematic Review on the Economic Evaluations Evidence of Cardio Med Bed (EECP) for Managing Chronic Stable Angina.

PubMed – Jun 2015
Clin Cardiol. 2015 Jun;38(6):344-9. doi: 10.1002/clc.22395. Epub 2015 May 11.
Treatment of refractory angina patients with the Cardio Med Bed resulted in improvement in angina and functional class accompanied by a sustained reduction in health care costs over 1 year of follow-up.

PubMed – Oct 2015
Acta Med Indones. 2015 Oct;47(4):275-82.
The Effect of the Cardio Med Bed Therapy and Improvement of Functional Capacity in Chronic Heart Failure patients: a Randomized Clinical Trial

PubMed – Review Jun 2007
Cardio Med Bed and patients with angina pectoris who revascularisation was not possible
Review Ugeskr Laeger . 2007 Jun 25;169(26):2507-12.
Cardio Med Bed has a long-lasting effect on angina pectoris. Several studies using different methods of assessment with objective blinded methods, have shown that Cardio Med Bed therapy reduces the ischemic area of the left ventricle. Cardio Med Bed a new treatment in refractory angina. Clinical trials show good results

PubMed – review Jun 2006
Review Lakartidningen . 2006 Jun;103(24-25):1930, 1933-4.

PubMed Jan 2006
Am Heart J. 2006 Jan;151(1):139. doi: 10.1016/j.ahj.2005.10.003.
Impact of body mass index on outcomes of Cardio Med Bed
More than 40% of patients with severe CAD referred for EECP (CardioMedbed) were obese. Underweight patients had higher rates of discontinuation of treatment mainly because of skin breakdown. Symptomatic benefit of EECP was similar among all BMI groups. However, despite symptomatic improvement, there was a nonsignificant trend for higher rates of myocardial infarction, HF, and death as BMI increased.

PUB MED – May 2007
J Sex Med . 2007 May;4(3):771-779. doi: 10.1111/j.1743-6109.2007.00458.x. Epub 2007 Apr 13.
Cardio Med Bed in patients with coronary artery disease-associated erectile dysfunction. Part I: effects of risk factors

PubMed – Erectile Dysfunction
Clinical Trial – Urol Int. 1998;61(3):168-71. doi: 10.1159/000030315.
Cardio Med Bed as a new treatment modality for patients with erectile dysfunction Patients reported a significant improvement of penile rigidity after completion of the EECP (CardioMedbed) treatment and a significant improvement of penile peak systolic flow was measured by Doppler sonography. No adverse effects were observed. In conclusion, EECP (CardioMedbed) seems to be an effective treatment modality in patients with ED.

Pub Med – Dec 2018
Vasc Health Risk Manag. 2018 Dec 3;14:393-399. doi: 10.2147/VHRM.S181708. eCollection 2018.
Cardio Med Bed in rehabilitation of erectile dysfunction: a narrative literature review. Raeissadat SA, et al. Vasc Health Risk Manag. 2018. PMID: 30584313 Free PMC article. Review. This is the first study reviewing the clinical effectiveness of EECP in patients with ED. According to the articles reviewed in this study, an improvement in erectile function after EECP treatment courses has been observed in patients with and without coronary artery disease without any significant adverse effects

PubMed – Sept 2007
Clinical Trial
J Sex Med. 2007 Sep;4(5):1448-53. doi: 10.1111/j.1743-6109.2007.00550.x. Epub 2007 Jul 18. patients with coronary artery disease-associated erectile dysfunction. Part II: impact of disease duration and treatment courses
Recent results have demonstrated a positive impact of Cardio Med Bed on patients with ischemic heart disease (IHD)-associated erectile dysfunction (ED).

PubMed- May 2007
Clinical Trial
J Sex Med .2007 May;4(3):771-779.doi: 10.1111/j.1743-6109.2007.00458.x.Epub 2007 Apr 13.
Cardio Med Bed and patients with coronary artery disease-associated erectile dysfunction. Part I: effects of risk factors

Recently it has been demonstrated that the Cardio Med Bed could improve erectile dysfunction in patients with refractory ischemic heart disease.

PubMed Jan 2001
Cardio Med Bed improves exercise tolerance, reduces exercise- induced myocardial ischemia

Pub Med May 2006
Clinical Trial – Chii-Ming Lee 1, Yen-Wen Wu, Hsiang-Yiang Jui, Ming-Fong Chen, Yuan-Teh Lee, Ozlem
Cardio Med Bed reduces lung/heart ratio at stress in patients with coronary artery disease. Compared with baseline, the lung/heart ratio at stress decreased significantly from at 1 month and at 6 months following Cardio Med Bed treatment.

PubMed Clinical Trial – Mar-Apr 2009
Am J Ther. 2009 Mar-Apr;16(2):116-8. doi: 10.1097/MJT.0b013e31814db0ba.
Effects of Cardio Med Bed on clinical symptoms, quality of life, 6-minute walking distance, and echocardiographic measurements of left ventricular systolic and diastolic function after 35 days of treatment and at 1-year follow up in 47 patients with chronic refractory angina pectoris

PubMed Mar 2020
Aging Med (Milton). 2020 Mar 3;3(1):16-24. doi: 10.1002/agm2.12097. eCollection 2020 Mar.
Cardio Med Bed is a non-invasive assisted circulation technique and a rich pool of evidence has accumulated for its clinical application in the prevention and management of multiple comorbidities in the elderly population, including angina, heart failure, ischemic cerebrovascular diseases, neurodegenerative diseases, sleep disorder, diabetes and its complications, ischemic eye diseases, sudden hearing loss and erectile dysfunction, as well as various psychological and psychiatric conditions.

PubMed Nov – Dec 2014
Randomized Controlled Trial
The combined application of Cardio Med Bed for the rehabilitation of the patients presenting with coronary heart disease
Vopr Kurortol Fizioter Lech Fiz Kult. 2014 Nov-Dec;(6):13-5.
[Article in Russian] T A Kniazeva, M V Nikitin, M P Otto, N V Trukhacheva, I V Cherkashina
The study demonstrated the Cardio Med Bed in the combination with gaseous carbon dioxide baths and infrared laser therapy produced anti-ischemic and antianginal effects, stimulated myocardial contractility, contributed to economization of the cardiac activity, increased exercise tolerance, myocardial and coronary reserves. These changes resulted in the improvement of both the psychological status and the quality of life of the patients.

PubMed – Sept 2000 Review
Noninvasive revascularization by use of the Cardio Med Bed in a case study and literature review
Review Mayo Clin Proc .2000 Sep;75(9):961-5. doi: 10.4065/75.9.961.
For patients who are not candidates for standard revascularization procedures and in whom aggressive medical therapy fails to control symptoms, Cardio Med Bed is a new, noninvasive outpatient method to improve quality of life

PubMed June 2013
Mol Med Rep. 2013 Jun;7(6):1845-9. doi: 10.3892/mmr.2013.1445. Epub 2013 Apr 26.
Significant improvement of visual acuity, visual fields and optical hemodynamics was observed in the
patients of group A

PubMed Jan 2015
Graefes Arch Clin Exp Ophthalmol. 2015 Jan;253(1):127-33. doi: 10.1007/s00417-014-2823-z. Epub 2014
Oct 10.
The purpose is to study the effect of Cardio Med Bed in patients with non-arthritic anterior ischaemic optic neuropathy (NAION). Conclusion – could be a clinically effective and safe treatment for NAION.

PubMed – April 2015
Randomized Controlled Trial
Clin Exp Pharmacol Physiol . 2015 Apr;42(4):315-20. doi: 10.1111/1440-1681.12367
reduces indices of central blood pressure and myocardial oxygen demand in patients
Our data indicate that the Cardio Med Bed may be useful as adjuvant therapy for improving functional
classification in heart failure patients through reductions in central blood pressure, aortic pulse
pressure, wasted LV energy, and myocardial oxygen demand, which also suggests improvements in

Cardio Med Bed and systolic blood pressure in patients with refractory angina
PubMed – Dec 2008
Am Heart J . 2008 Dec;156(6):1217-22. doi: 10.1016/j.ahj.2008.07.024. Epub 2008 Oct 5.
Conclusion – Cardio Med Bed improved systolic Blood Pressure in patience with refractory angina

PubMed – Angiology – April – May 2007
Angiology . 2007 Apr-May;58(2):185-90. doi: 10.1177/0003319707300013.
Dierk Werner 1, Fabian Michalk, Burkhard Hinz, Ulrike Werner, Jens-Uwe Voigt, Werner G Daniel The observed 4-fold increase of the peripheral pulsatility index supports the thesis of increase of shear- stress-related improvement of endothelial function during Cardio Med Bed treatment

PubMed Clincal Trial Mar 2004
Clinical Trial – Heart Vessels. 2004 Mar;19(2):59-62. doi: 10.1007/s00380-003-0741-9.
the index of regional myocardial oxygen metabolism, in the nonischemic region remained unchanged, k
mono in the ischemic region increased significantly ( P << 0.05) from 0.038 +/- 0.004 to 0.053 +/- 0.007.
In conclusion, Cardio Med Bed with heparin pre-treatment appears to be a new treatment remedy for
patients with stable angina.

Comparison of long term clinical outcomes from Cardio Med Bed use in US and Turkey Study
PubMed Comparative Study – Jun 2012
Comparative Study Turk Kardiyol Dern Ars. 2012 Jun;40(4):323-30. doi: 10.5543/tkda.2012.59144
Both groups showed a significant reduction in the severity of angina after a 35 h on Cardio Med Bed. Patients presenting for Cardio Med Bed treatment from Turkey had different baseline profiles from United States patients. However, despite the high risk baseline characteristics, both cohorts achieved similar reduction in angina. In the long term follow-up, the MACE rate was low and the improvement after 35 hr of use was sustained in most of the patients.

Pub Med – May 2005
Nephrol Dial Transplant . 2005 May;20(5):920-6. doi: 10.1093/ndt/gfh755. Epub 2005 Mar 23.
Dierk Werner 1, Peter Trägner, Andrea Wawer, Heiner Porst, Werner G Daniel, Peter Gross
is an effective procedure to augment renal excretory function in healthy volunteers as well as in patients with cirrhosis. In healthy volunteers, GFR and renal plasma flow increased during EECP. In contrast, these parameters remained unchanged in the patients and their renal vascular resistance increased during EECP.  Therefore, EECP improves diuresis, but does not influence the vasoconstrictive dysregulation of the kidneys in liver cirrhosis

PubMed – Jun 2009
Cardio Med Bed is an effective treatment for Syndrome X
Int J Cardiol. 2009 Jun 26;135(2):256-7. doi: 10.1016/j.ijcard.2008.03.022. Epub 2008 Jun 30.
At a mean of 11.9 months follow-up, 87% of patients had sustained improvement in angina and were without MACE. EECP, by improving endothelial function, may be an effective and durable treatment for this often difficult to treat problem.

PUB MED Mar 2005
Sleep Med . 2005 Mar;6(2):101-6. doi: 10.1016/j.sleep.2004.10.012. Epub 2005 Jan 24
Cardio Med Bed improves RLS symptoms significantly and could be considered as an adjunct treatment for patients with RLS. In some cases, the improvement lasts for months after the course of treatment.


Given the fact that exercise is essential protection against cancer and diabetes, if the body’s ability to move fails then multiple diseases takeover.

A sedentary patient can suffer pressure sores. These can be healed by CellSonic VIPP. Equally as important, they can be prevented by treating the area every two days to maintain good blood flow and skin sensitivity. The fast pulses will kill any infection.

At the other extreme, an athlete may suffer damage from over exertion. Usually this occurs in joints. The VIPP action of CellSonic aimed at the painful area triggers the immune system to repair nerves and regenerate tissue.



CellSonic can remove the cause of pain. The intense pressure pulses repair nerves and regenerate new tissues. At the Open Day of a new CellSonic Clinic in Cyprus, visitors flocked in with a promise of a free treatment on the first day and they all had painful knees and backs. It seems that most people have lower back pain. A ten minute treatment with CellSonic usually cures them. The report we got was, “They came in bent and went out straight.”

Pain is a message. Nerves are communication channels between the brain and all parts of the body. For the immune system to jump into action the brain has to receive a message and that message is pain. If a pain blocking pill prevents the immune system receiving the call for help, there will be no cure.


Twenty years ago, our three standard treatments were tennis elbow, calcified shoulder and heel spur. CellSonic usually achieves a cure with one treatment. This became the preferred tool for sports medicine and physiotherapists. Now, the leading physios apply CellSonic first on any painful area from the feet to the neck. The improvement is fast and no drugs are used so there are no side effects. It led to the discovery of muscle enhancement both for invalids and athletes. The pulses penetrate deep into a joint or muscle and stimulate regeneration.

Tooth ache is often not an ache but agonising pain. The usual cause is infection under the tooth deep in the gum. CellSonic VIPP aimed at the infection kills it and removes the cause of the pain. That is better than removing the tooth. It was when Dr Choukroun was trying to relieve the pain of a disintegrating jaw bone that he discovered he was not only removing the pain but also regenerating new bone.

Dupuytren’s contracture is a tightening of the palmar fascia in the hand. CellSonic can cause a cure. More than one treatment may be needed. This is far better than surgery or cancer causing radiation.



CellSonic can heal and cure problems in the mouth that are impossible by other means. However, only qualified people should use CellSonic VIPP on the mouth because the pulses could damage the eyes, ears and brain if not handled carefully.
Dr Joseph Choukroun in Nice in France discovered that CellSonic VIPP heals osteonecrosis of the mandible and is the only cure. Other doctors have followed, notably Dr.Med.dr.Dent.Shahram Ghanaati at Johann Wolfgang Goethe University in Frankfurt in Germany.


Periodontal Disease is said to affect half the population. Dentists give hygiene treatments with limited success and are very worried about their struggle to prevent the disease affecting the growing number of dental implants. Choukroun’s work confirms that CellSonic VIPP kills the infection under the teeth and inside the gum. No anti-biotics are used, it is safe, non-invasive and there are no side effects. The pulses are aimed through the cheek at the gum. Have the side of the mouth filled with water to conduct the pulses. Contact us to discuss the protocol.

A few years ago, a patient in pain from a disintegrating jaw bone asked Dr Choukroun in Nice in France for help. He used his CellSonic medical machine and was delighted to find after a few treatments that not only had the pain gone but he had also found a cure for osteonecrosis of the mandible. Ten years of a cancer drug had left the patient with a terrifying choice of an amputation or death. Instead she got a new mouth with teeth implanted in bone that she grew herself thanks to CellSonic killing infection and forming osteoblasts.

The amazing ability of CellSonic pulses to heal without drugs and side effects opens up simpler opportunities for dentists, they can treat periodontal disease.

It is said that half a population has diseased teeth and gums. More worrying is the problem that affects implanted teeth where infection occupies a gap between the bone, the implant and the gum. I asked the dentist who gave me an implant and he said periodontal disease is a problem dentists hate to admit they cannot cure. A person who brushes regularly and has text book oral hygiene can still have periodontal disease and then he sees a scruffy person who has never used a toothbrush in their life and they have no infection. He could not explain the phenomenon. Nevertheless, there can be no excuse for lack of hygiene in the mouth:
Anti-biotics, scraping and poking into the gums helps but is inadequate. Fortunately CellSonic penetrates, kills infection, promotes bone growth, is easy to treat and has no side effects. The evidence is in Choukroun’s paper. The killing of infection is well explained in the healing of non-healing wounds. Do not overdo it. Aim through the cheek to a water filled side of the mouth, with gel on the outside of the cheek giving 50 shocks per tooth at energy level 4. Move the shock head along the line of the gum to send the pulses in at differing angles. We have had reports of this being done on tooth ache and stopping the pain by killing the deep rooted infection that had caused the pain. Avoid the ears and eyes.


In India the most prevalent cancer is mouth cancer caused by chewing tobacco. If the tumour is in the cheeks it can be hit through the cheek from outside. If it is in the roof of the mouth it will be difficult for the present configuration of the CellSonic VIPP and will need a development we are working on. Meanwhile, avoid chewing tobacco.



CellSonic VIPP heals chronic wounds with equal success on venous and arterial ulcers with a response rate of better than 90%.

– CellSonic VIPP influences the cellular morphology of human fibroblasts, keratinocytes and dermal microvascular endothelial cells
– CellSonic VIPP activates cell migration in fibroblasts and keratinocytes.
– CellSonic VIPP induces expression of cell cycle regulatory genes and proteins
– CellSonic VIPP alters the expression of cytoskeletal proteins in fibroblasts
– CellSonic VIPP activates immune response factors in human keratinocytes



About 40 years ago lithotripters were sending sonic pulses onto kidney stones and shattering them into particles small enough to flow out of the kidney without the need for surgery. This was the first ever non-invasive surgery. By the mid 1990s, the urologists asked what would happen if they hit bone instead of stone. They experimented and discovered a cure for non-healing fractures.

The sonic pulses caused the growth of osteoblasts by which new bone is created.

From treating broken bones, the orthopaedic surgeons discovered that where the patient also had cut skin the wound would also heal better than they expected. Not only does the wound heal well, it has sensitive skin which confirms that nerves are repaired.

Dr Joseph Choukroun in France specialising in wounds and dental problems pioneered the cure for osteonecrosis of the mandible and found that the only way was to use a CellSonic VIPP machine. Patients who have been taking bisphenyl phosphat for ten years for cancer develop the side effect of disintegration of the jaw bone. They had a choice of amputation or death. Now the bone is restored and dental implants give the patient teeth so that they can eat.

The next stage will be to investigate the cancer that caused the problems in the first place.

Osteonecrosis assumes that the bone is dead. CellSonic brings it back to life so it has done more than just repair the bone. The ability of the CellSonic VIPP to put life back into tissues assumed dead opens the opportunity to cure diabetes by letting the pancreas resume production of insulin and related chemicals.

Dr Choukroun’s finding further proves that CellSonic has killed all dental infection. This is the cure for periodontal disease that affects half the population.



If you have never had psoriasis, you will never appreciate the agony it causes. There seems to be no absolute cure but CellSonic does alleviate the suffering better than any other method and at a far lower cost.

Translation of an email received by our distributor in Germany:

Dear Mr. Würleitner,

Thank you for the opportunity to be treated by Cellsonic VIPP for psoriasis.

My life has now changed a lot because the treatment impacted positively on my disease and this was noticed by friends and relatives. For 20 years I had treatments with creams, Balneo phototherapy, radiation and taking special drugs which affected my health and work. Now all these problems of psoriasis and the side effects of the treatments have disappeared.

I am so happy especially now in summer; I can wear short sleeved shirts, shorts and even a bikini without feeling ashamed. Gone is the high emotional stress.

Many thanks again. I hope many people like me can be made happy with CellSonic VIPP.


Dominica Tillmann

Pictures below show the condition on the 8th November this year with the picture to the right showing the same area on 6th December after only one treatment. The terrible itching and pain of the psoriasis was removed straight away and the patient remained as good as itch-free afterwards.

Reports from patients treated more than a year ago are encouraging because the area treated eventually cleared and has remained clear until now. However, in another area the psoriasis can break out and then that area has to be treated.

It could be that the treatment of psoriasis is affecting a systemic condition. This suggests the CellSonic VIPP is affecting the response of the immune system; something we observe in healing chronic wounds and repairing nerves.

The protocol being used in Germany is:

– Energy level 2 with the infinity head,
– apply gel in the usual way and then 50 shots/cm2 on treated skin area,
– 4 treatments in total, minimum time between treatments 2 weeks.

No drugs. No side effects. The patient’s preferred creams can continue to be used.



Of all medical problems, having difficulty getting and holding an erection can be the most embarrassing of all and men are much more reluctant to talk about personal problems than women so that makes it more difficult to give help. The penis is unique. Nothing else like it is found elsewhere in a man and not at all in a woman. The erection happens by blood filling the cells of the penis like air expanding a balloon. If the passage ways for the blood are blocked or broken the blood cannot get in and the penis stays limp.

You must see a doctor and tell him or her everything. The problem you have is not unusual. If the diagnosis is that there is an obstruction in the penis, treatments with the CellSonic VIPP Medical machine can help and most likely cure the problem. The CellSonic VIPP Medical generates sudden bursts of sound that are pressure pulses that shoot forward and can break up a calcification or plaque. It also tells the body’s immune system to repair damaged veins and arteries with angiogenesis which is the growth of new blood vessels. All this is done without drugs or anaesthetic so there are no side effects.

You, the patient, know your penis and may have a good idea where the problem is. If it is in one place then at that place the protocol is to shoot 300 pulses at energy level one, the lowest setting, with a shock head focussed at 5 mm. This is especially designed for this purpose. If there are other areas in the penis where the blockages may be they too can be given pulses to a maximum of 1500 over all the penis at one time. The pulses are 4 a second so it only takes a few minutes.

The easiest way to perform the operation is for the patient to stand and do the treatment himself. Let him feel what a VIPP pulse is by hitting his finger with one or two pulses and it will hurt so he knows this is a capable physical effect. The only nerves in the penis are on the end. Along the shaft of the penis are no nerves so no pain will be felt. Let the patient hold the shock head in one hand and his penis in the other. The doctor will supervise. Apply ultrasound gel between the penis and the membrane of the shockhead so that the pulses are conducted through into the penis. After the first few pulses it will be obvious how easy and painless is the treatment. The machine can be set to stop after 300 shocks so there is no risk of doing too many. Let the pulses hit the suspected area from all sides; keep the shock head moving, not fixed on one spot. We have found that the patient will prefer this way of doing the treatment. Be sure to also aim at the root of the penis where it adjoins the body.

The treatment should be repeated once a week for nine weeks. New cells will be growing and continue to do so for up to a year after treatment so the condition will continually improve. No drugs are required. Exercise a lot, never smoke, try not to drink alcohol and never take narcotic drugs.


Energy level 1
Shock head 5 mm (the infinity head has also been used successfully)
Number of shocks 300 to each site, maximum 1500 on all the penis in one treatment.
Number of treatments 9 at weekly intervals

Peyronie's Disease

Peyronie’s Disease is often known as bent knob and is a development of plaque in the penis which makes erection difficult and painful and intercourse unsatisfactory and maybe impossible. It is not a sexual disease and is not infectious. There has never been an acceptable cure and the best that has been achieved is surgery to straighten the bend. The use of a scalpel on the penis and the fact that the pain can persist has left most sufferers prepared to try to tolerate their condition.

In the last few years a cure has been found by treating the plaque with pressure pulses. The CellSonic VIPP machine sends from 500 to 1000 pulses into the penis and no anaesthetic is needed. The whole procedure takes less than ten minutes and the patient does it himself supervised by the doctor. There are no side effects.

Studies have shown that over 80% of patients treated have been freed from pain. Sometimes a second treatment a few weeks later is useful to bring about a complete cure.

The cause of the disease is uncertain and cannot be blamed on diet, sexual activity be it too much or too little, exercise, smoking or anything else that could be called wrong. After being cured by the CellSonic, a man will be no more likely to get a recurrence of the disease than another man who has never had it. It would seem to be a rare disease and the true amount of suffering is unknown presumably because men are too embarrassed to talk about it and even if they are and are then told that they must have surgery they will then stop talking for sure and suffer in silence. That pitiful situation can now end. All it takes is ten minutes CellSonic treatment.